Guidelines for Evaluation of Nanopharmaceuticals in India

Guidelines for Evaluation of Nanopharmaceuticals in India

Inter-Ministerial Committee, GOI coordinated by DBT accepted “Guidelines for Evaluation of Nanopharmaceuticals in India” on 05/07/2019. These guidelines may serve as a useful document for manufacturers, importers of nanopharmaceuticals and other stakeholders involved in R&D of nanopharmaceuticals. The guidelines will be releasing soon.